BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18837946)

  • 1. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
    Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
    Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.
    Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D
    Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free circulating DNA as possible tumour marker in colorectal cancer.
    Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
    Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations.
    Guadalajara H; Domínguez-Berzosa C; García-Arranz M; Herreros MD; Pascual I; Sanz-Baro R; García-Olmo DC; García-Olmo D
    Cancer Detect Prev; 2008; 32(1):39-44. PubMed ID: 18400415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA integrity in plasma and serum of patients with malignant and benign diseases.
    Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
    Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
    Thijssen MA; Swinkels DW; Ruers TJ; de Kok JB
    Anticancer Res; 2002; 22(1A):421-5. PubMed ID: 12017326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.
    Frattini M; Gallino G; Signoroni S; Balestra D; Battaglia L; Sozzi G; Leo E; Pilotti S; Pierotti MA
    Ann N Y Acad Sci; 2006 Sep; 1075():185-90. PubMed ID: 17108210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy.
    Cheng C; Omura-Minamisawa M; Kang Y; Hara T; Koike I; Inoue T
    Cancer Sci; 2009 Feb; 100(2):303-9. PubMed ID: 19200259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating free tumor DNA and colorectal cancer.
    Lecomte T; Ceze N; Dorval E; Laurent-Puig P
    Gastroenterol Clin Biol; 2010 Dec; 34(12):662-81. PubMed ID: 20832215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.
    Frattini M; Gallino G; Signoroni S; Balestra D; Lusa L; Battaglia L; Sozzi G; Bertario L; Leo E; Pilotti S; Pierotti MA
    Cancer Lett; 2008 May; 263(2):170-81. PubMed ID: 18395974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative analysis of circulating DNA in serum of cancer patients].
    Tu H; Gao HF; Fu SL; Chen H
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):606-8. PubMed ID: 15634521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer.
    Czeiger D; Shaked G; Eini H; Vered I; Belochitski O; Avriel A; Ariad S; Douvdevani A
    Am J Clin Pathol; 2011 Feb; 135(2):264-70. PubMed ID: 21228367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.
    Board RE; Williams VS; Knight L; Shaw J; Greystoke A; Ranson M; Dive C; Blackhall FH; Hughes A
    Ann N Y Acad Sci; 2008 Aug; 1137():98-107. PubMed ID: 18837931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free DNA in the serum of cancer patients and the effect of therapy.
    Leon SA; Shapiro B; Sklaroff DM; Yaros MJ
    Cancer Res; 1977 Mar; 37(3):646-50. PubMed ID: 837366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of plasma cell-free DNA in patients with gastric cancer.
    Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
    Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
    Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
    Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.